Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,967.00
Bid: 1,969.00
Ask: 1,972.00
Change: 11.00 (0.56%)
Spread: 3.00 (0.152%)
Open: 1,963.00
High: 1,994.00
Low: 1,959.00
Prev. Close: 1,956.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: RBS Misses Gains After Swinging To Operating Loss

Fri, 05th Aug 2016 07:33

LONDON (Alliance News) - Stocks in London were higher Friday morning, with investors still celebrating the Bank of England's easing measures, but Royal Bank of Scotland Group shares were missing out after it said it swung to an operating loss in the first half of 2016.

The FTSE 100 index was up 0.6%, or 39.44 points, at 6,779.60. The FTSE 250 was up 0.3% at 17,293.09 and the AIM-All Share up 0.3% at 764.17.

RBS shares were down 5.2%, the worst performer in the FTSE 100. The lender, which is 73%-owned by the UK government, said it made an operating loss of GBP274.0 million in the half to the end of June, swung from a GBP261.0 million profit a year prior.

RBS's loss for the half, attributable to ordinary shareholders after its final dividend access payment, was GBP2.05 billion, compared to a GBP179.0 million loss a year before. This includes the dividend access payment, which amounted to GBP1.19 billion, plus GBP1.31 billion in litigation and conduct costs.

RBS said its adjusted operating profit for the half, which removes one-off costs along with litigation and conduct charges, was GBP1.16 billion, down from GBP2.89 billion a year before. Adjusted operating profit for the bank's Personal & Business Banking, Commercial & Private Banking and Corporate & Institutional Banking franchises fell 15% in the half and the profit was further hit by increased volatility losses.

RBS said its common equity tier 1 ratio was 14.5% at the end of June, still ahead of its 13.0% target. The CET1 ratio is a key measure of bank profitability and the ability of the lender to pay dividends.

At the top end of the large-cap index was Hikma Pharmaceuticals, up 2.8%, recovering some of the ground lost Thursday, when it fell 17%. The drug company late Wednesday said it expects full-year operating profit within its Generics division to be hit by changes in revenue mix, but maintained its guidance on its other two divisions.

In the FTSE 250, Ibstock was up 7.1%, the biggest mid-cap gainer. The clay bricks manufacturer said it has contingency plans in place to enable it to balance production with sales volumes for the remainder of the year as a response to the uncertainty resulting from the UK's vote to leave the European Union.

The building materials company said its key focus under these plans will be the management of stock levels and said capacity will be flexed to balance production with sales levels as necessary. Ibstock said it will manage its cost base in response to the evolution of its markets as visibility improves.

The comments came as Ibstock posted revenue for the six months ended June 30 of GBP210.0 million, up from GBP148.9 million a year earlier. Pretax profit came in at GBP37.9 million from GBP77.0 million a year earlier, including GBP51.8 million in net exceptional benefits a year earlier which did not repeat. Ibstock declared an interim dividend of 2.4 pence per share, having offered no interim dividend a year earlier.

Shares in Esure Group were down 4.7%. The insurer trimmed its interim dividend to 3.0 pence from 4.2p a year earlier and below the 3.5p forecast by DividendMax. Esure said it was cutting the dividend in order to fund growth across its divisions.

Pretax profit for the half-year to the end of June was GBP30.7 million, down 69% from GBP97.6 million a year earlier. The 2015 half-year pretax profit had been flattered by a one-off gain booked on the value of esure's holding in GoCompare. Underlying pretax profit, taking out the one-off effects, was essentially flat in the first half, at GBP45.6 million versus GBP46.5 million a year prior.

In mainland Europe, the CAC 40 index in Paris was 0.7% and the DAX 30 in Frankfurt was 0.2%.

In Asia on Friday, the Japanese Nikkei 225 index ended flat. The Chinese Shanghai Composite dropped 0.2%, while the Hang Seng index in Hong Kong continues up 1.4%.

On Thursday, the BoE's Monetary Policy Committee voted unanimously to cut UK interest rates by 25 basis points to 0.25%.

In addition, the BOE expanded the size of its asset purchase facility programme, with the increase totalling GBP170 billion as a whole. It included the expansion of UK government bonds purchases by GBP60 billion to GBP435 billion, up to GBP10 billion in UK corporate bonds and introduced a Term Funding Scheme, worth "around GBP100 billion", aimed to help reinforce the transmission of the interest rate cut to the real economy.

The highlight in the economic calendar Friday is US nornfarm payrolls, scheduled at 1330 BST. US payrolls are expected to come in at 180,000, down from the 287,000 seen in June, according to FXStreet.com.

Average hourly earnings are expected to grow 0.2% on a monthly basis, compared to a 0.1% rise in June, and 2.6% year-on-year, flat against the June reading. The US unemployment rate is expected to show a fall to 4.8%, compared to the 4.9% seen in June.

Elsewhere, there are UK Halifax house prices at 0830 BST and the US Baker Hughes US oil rig count at 1800 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 07:43

LONDON BRIEFING: AB Foods hails Primark; Beazley premiums rise

(Alliance News) - London's FTSE 100 is called to open in the red on Tuesday, following Asian equities lower, as the good feeling in equity markets after the softer US jobs data on Friday gives way to some caution.

Read more
6 Nov 2023 12:01

Berenberg stays at 'hold' on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.

Read more
3 Nov 2023 09:31

LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 Nov 2023 15:12

London close: Stocks rise as BoE keeps rates steady

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.